Global Optic Nerve Disorders Treatment Market Size, Share, Forecast Report, 2020-2027

The global Optic Nerve Disorders Treatment market garnered revenue around USD 14.2Billion in 2019 and projected to reach USD 19.4 Billion in 2027, with at a compound annual growth rate (CAGR) 4.1% throughout the estimate period from 2020 to 2027. Optic nerve disorders treatment comprise medications and surgery, which treat optic nerve disorders (glaucoma, optic neuritis, and other related disorders). The optic nerve is a bundle of more than 1 million nerve fibers that carry visual messages. Damage to an optic nerve can cause vision loss depending on severity of damage to the optic nerve. Optic nerve disorders are a group of disorders related to optic nerves caused due to damage to optic nerves, which can lead to vision loss or eventually complete blindness.

Growth of the optic nerve disorders treatment market can be ascribed to increase in prevalence of optic nerve disorders and other related eye disorders across the globe. North America dominated the optic nerve disorders treatment market in 2018 and is projected to continue its dominance during the forecast period, owing to the rise in the number of prescriptions for glaucoma treatment in the region and high prevalence of optic nerve disorders.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Optic Nerve Disorders Treatment market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Optic Nerve Disorders Treatment market growth.

The global Optic Nerve Disorders Treatment market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

the global market include Santen Pharmaceutical Co., Ltd., Allergan plc. Novartis AG, Pfizer, Inc., Bausch Health Companies, Inc., Aerie Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Bionure Farma, S.L., and Mallinckrodt Pharmaceuticals. Novartis AG, Allergan plc., and Santen Pharmaceutical Co., Ltd.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Global Optic Nerve Disorders Treatment Market: Segmentation

• Optic Nerve Disorders Treatment Market, by Treatment Type
  • Pharmacological Treatment
    • Prostaglandins
    • Beta Interferons
    • Beta Blockers
    • Alpha-adrenergic agonist
    • Carbonic Anhydrase Inhibitors
    • Corticosteroids
    • Combination Drugs
    • Others (Rho kinase inhibitors, Monoclonal antibodies, cholinergic drugs, and Immunoglobulins)
  • Surgery
• Optic Nerve Disorders Treatment Market, by Indication
  • Glaucoma
  • Optic Neuritis
  • Optic Neuropathy
    • Arteritic Ischemic Optic Neuropathy
    • Non-arteritic Ischemic Optic Neuropathy
    • Congenital Optic Atrophy
  • Others (optic nerve hypoplasia (ONH), optic nerve head drusen, optic nerve pit, coloboma of optic nerve, and idiopathic intracranial hypertension)
• Optic Nerve Disorders Treatment Market, by End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Clinics
  • Others (Home Care Settings, academic & research institutes)

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Rest of EU
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
• Central & South America
  • Brazil
  • Argentina
  • Rest of Central & South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Rest of MEA